Cherney
Daniel P. Cherney, Hampton, NJ US
Patent application number | Description | Published |
---|---|---|
20110236745 | MICROPOROUS MEMBRANE, METHODS FOR MAKING SUCH FILM, AND THE USE OF SUCH FILM AS BATTERY SEPARATOR FILM - Embodiments of the present invention generally relate to microporous membrane, methods for making microporous membrane, and the use of microporous membrane as battery separator film. More particularly, the invention relates to a microporous polymeric membrane including a paraxylylene polymer or copolymer, particularly in combination with a polymeric microporous membrane. The paraxylylene polymer or copolymer can be formed on or laminated to the microporous polymeric membrane. | 09-29-2011 |
20140256055 | EXPLORATION METHOD AND SYSTEM FOR DETECTION OF HYDROCARBONS - A method for detecting hydrocarbons is described. The method includes performing a remote sensing survey of a survey location to identify a target location. Then, an underwater vehicle (UV) is deployed into a body of water and directed to the target location. The UV collects measurement data within the body of water at the target location, which is then analyzed to determine whether hydrocarbons are present at the target location. | 09-11-2014 |
20140284465 | EXPLORATION METHOD AND SYSTEM FOR DETECTION OF HYDROCARBONS WITH AN UNDERWATER VEHICLE - A method for detecting hydrocarbons with an underwater vehicle equipped with one or more measurement components is described. The method includes navigating the UV within the body of water; monitoring the body of water with measurement components associated with the UV to collect measurement data. The collected data from the UV is used to determine whether hydrocarbons are present and at the location. | 09-25-2014 |
Daniel Patrick Cherney, Hampton, NJ US
Patent application number | Description | Published |
---|---|---|
20130265063 | METHOD AND APPARATUS FOR DETECTING THE PRESENCE OF WATER IN A CURRENT OF LIQUID HYDROCARBONS - Provided is an apparatus for detecting the presence of water in a current of liquid hydrocarbons. The apparatus comprises at least one pair of electrodes for detecting the presence of water in a sample zone in the current of liquid hydrocarbons located therebetween; alternating current generating circuitry for generating an alternating current between the electrodes; measuring circuitry for measuring the electrical impedance of the current of liquid hydrocarbons between the electrodes; and a processor for collecting data from the measuring circuitry, processing the data and outputting the data for use in detecting the presence of water in the current of liquid hydrocarbons. A method is provided for detecting the presence of water in a current of liquid hydrocarbons and for quantifying the amount of free water present in a current of liquid hydrocarbons. An apparatus is provided for quantifying the amount of free water present in a current of liquid hydrocarbons. | 10-10-2013 |
20150152340 | DESALTER EMULSION SEPARATION BY EMULSION RECYCLE - A petroleum desalting process in which fluid from interfacial boundary layer between the settled water layer and the settled oil layer or emulsion-water layer in the vessel is withdrawn from the desalter and recycled to the crude oil inlet of the desalter to improve separation of the oil and water phases. | 06-04-2015 |
20150175904 | DESALTER OPERATION - A petroleum desalting process in which the role played by the oil/bulk-resolved-water interface in the dehydration of the stabilized emulsion which forms in the desalter is recognized. The desalting process is improved by introducing the demulsifier and chemical high voltage electrodes. Water droplets in the mixture coalesce and settle towards the bottom of the vessel. A stabilized emulsion layer formed from the oil and the water with additives into the water phase and/or injecting chemical additives directly in the vicinity of the water/oil interface. This improved methodology that makes the rapid and effective delivery of chemical demulsifiers to the rag layer and/or oil/bulk-resolved-water interface possible. In operation, the desalting is carried out by mixing a crude oil to be desalted with water and passing the mixture of oil and water to the desalter vessel. The mixture enters the desalting vessel in the form of an emulsified mixture which is then separated by application of an electric field between emulsion-stabilizing solids from the oil forms above the interface between the denser water layer and the supernatant oil layer. A chemical demulsifier is added to the water layer in the region of the stabilized emulsion layer and/or directly into the emulsion layer itself. The separated water is removed as effluent through a water outlet at the bottom of the vessel and desalted oil is removed from the oil layer through an oil outlet at the top of the vessel. | 06-25-2015 |
David Z.i. Cherney, Toronto CA
Patent application number | Description | Published |
---|---|---|
20140303097 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes. | 10-09-2014 |
20140315832 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus. | 10-23-2014 |
20160000816 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes. | 01-07-2016 |
20160038523 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes. | 02-11-2016 |
20160038525 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF - The present invention relates to certain SGLT-2 inhibitors for treating, preventing, protecting against and/or delaying the progression of chronic kidney disease in patients, for example patients with prediabetes, type 1 or type 2 diabetes mellitus. | 02-11-2016 |
Emily Charlotte Cherney, Newtown, PA US
Patent application number | Description | Published |
---|---|---|
20160137652 | IMMUNOREGULATORY AGENTS - Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided. | 05-19-2016 |
20160137653 | IMMUNOREGULATORY AGENTS - Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided. | 05-19-2016 |
Nicholas Cherney, Norwalk, CT US
Patent application number | Description | Published |
---|---|---|
20110202450 | Exchange Traded Note Indexed to a Single Product - Systems and methods are provided for creating and managing Exchange Traded Notes (ETNs) which are indexed to a single product such as a stock or another financial instrument. The ETN may be created by selecting a stock, and conducting a broker poll to determine the level of the index related to the ETN. | 08-18-2011 |
Patrick Lyle Cherney, Duncan, OK US
Patent application number | Description | Published |
---|---|---|
20130186632 | METHODS AND APPARATUSES FOR WIPING SUBTERRANEAN CASINGS - An object for wiping a subterranean casing is described herein. The object may include an inner core with a first width. The ball may also include a deformable layer surrounding the inner core. The deformable layer may have a second width. The first width may be smaller than a diameter of at least one baffle within the subterranean casing. The second width may be larger than or equal to the largest inner diameter of the subterranean casing. | 07-25-2013 |
20130213658 | METHODS AND SYSTEMS FOR WIPING SURFACES WHEN PERFORMING SUBTERRANEAN OPERATIONS - Improved darts and methods of using these darts in subterranean wells are disclosed. The improved dart comprises a foam portion and a rubber portion coupled to the foam portion. A dart nose is coupled to at least one of the foam portion and the rubber portion. The foam portion and the rubber portion are configured to interface with an inner surface of at least one of a well bore wall, a pipe, and a casing string. | 08-22-2013 |
Robert J. Cherney, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20130045964 | MANDELAMIDE HETEROCYCLIC COMPOUNDS - Disclosed are compounds of Formula (I) or stereoisomers, salts, or prodrugs thereof, wherein: Q is, or R | 02-21-2013 |
Robert J. Cherney, Newton, PA US
Patent application number | Description | Published |
---|---|---|
20120149733 | PIPERIDINYL COMPOUND AS A MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY - The present application describes the compound of formula (I): | 06-14-2012 |
Robert J. Cherney, Newtown, PA US
Patent application number | Description | Published |
---|---|---|
20090124668 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY - The present application describes modulators of MCP-1 of formula (I): | 05-14-2009 |
20110086857 | N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1,- 3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE, A DUAL MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESSES - The present invention provides a novel antagonist: N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide: | 04-14-2011 |
20130158039 | N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1,- 3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE, A DUAL MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESSES - The present invention provides a novel antagonist: N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide: | 06-20-2013 |
20130237566 | HETEROCYCLIC COMPOUNDS AS S1P1 AGONISTS FOR THE TREATMENT OF AUTOIMMUNE AND VASCULAR DISEASES - Disclosed are compounds of Formula (I) or stereoisomers, salts, or prodrugs thereof, wherein: W is CH | 09-12-2013 |
20140088109 | N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1,- 3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE, A DUAL MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESSES - The present invention provides a novel antagonist: N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin -1-yl)cyclohexyl)acetamide: | 03-27-2014 |